| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Capecitabine | FAERS: 2 | US FAERS | |
| 2 | Estradiol | FAERS: 2 | US FAERS | |
| 3 | Lenalidomide | FAERS: 2 | US FAERS | |
| 4 | Tolvaptan | FAERS: 2 | US FAERS | |
| 5 | Duloxetine Hydrochloride | FAERS: 1 | US FAERS | |
| 6 | Isotretinoin | FAERS: 1 | US FAERS | |
| 7 | Olmesartan Medoxomil | FAERS: 1 | US FAERS | |
| 8 | Sunitinib | FAERS: 1 | US FAERS | |
| 9 | Tinzaparin | FAERS: 1 | US FAERS | |
| 10 | Warfarin | FAERS: 1 | US FAERS | |
| 11 | Pamidronate | OFFSIDES | ||
| 12 | Vinorelbine | OFFSIDES | ||
| 13 | Zoledronic Acid | OFFSIDES | ||
| 14 | valdecoxib | OFFSIDES |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120241
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.